AnPac Bio-Medical Science... (ANPC)

NASDAQ: ANPC · Real-Time Price · USD

4.30

-0.14 (-3.15%)

At close: May 19, 2023, 7:59 PM

AnPac Bio-Medical Science Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q2 2020	Q4 2019	Q3 2019	Q4 2018
Period Ending	Apr 5, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Jun 30, 2020	Dec 31, 2019	Sep 30, 2019	Dec 31, 2018
Cash & Equivalents	n/a	1.87M	7.58M	6.89M	462K	9.25M	5.46M	8.58M	9.02M	3.02M	9.97M	6.13M	23.98M	12.89M
Short-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	1.08M	855K	836K	742K	923K	803K	670K	805K	883K	1.61M	2.33M	3.9M	3.46M
Other Long-Term Assets	n/a	n/a	n/a	n/a	n/a	2.06M	459K	459K	466K	464K	862K	1M	1.98M	1.46M
Receivables	n/a	5.54M	10.77M	7.52M	4.57M	5.55M	8.09M	26.64M	8.22M	9.07M	3.12M	1.29M	8.55M	3.02M
Inventory	n/a	210K	384K	432K	424K	490K	347K	451K	972K	312K	205K	313K	268K	62K
Other Current Assets	n/a	6.08M	3.39M	3.16M	4.49M	8.25M	8.42M	5.04M	15.09M	8.89M	11.6M	14.44M	5.63M	4.88M
Total Current Assets	n/a	13.7M	37.02M	31.53M	16.98M	23.55M	22.32M	40.71M	33.3M	21.29M	24.9M	22.17M	38.42M	20.85M
Property-Plant & Equipment	n/a	24.39M	27.28M	27.54M	27.93M	20.26M	20.36M	19.47M	19.18M	19.27M	18.82M	18.87M	19.12M	18.14M
Goodwill & Intangibles	n/a	1.3M	1.33M	1.24M	22.32M	22.75M	29.61M	7.67M	7.88M	7.99M	8.3M	8.62M	8.6M	8.85M
Total Long-Term Assets	n/a	26.77M	29.46M	29.61M	50.99M	43.94M	51.23M	28.26M	28.33M	28.6M	29.59M	30.81M	33.6M	31.91M
Total Assets	n/a	40.47M	66.48M	61.15M	67.97M	67.49M	73.55M	68.97M	61.63M	49.89M	54.49M	52.98M	72.02M	52.76M
Account Payables	n/a	2.11M	5.3M	3.31M	3.72M	2.73M	1.68M	1.21M	687K	2.13M	1.51M	1.8M	3.94M	1.62M
Deferred Revenue	n/a	4.96M	4.41M	4.56M	4.17M	4.17M	4.81M	5.09M	4.04M	3.68M	2.36M	2.45M	2.71M	4.31M
Short-Term Debt	n/a	5.8M	1.07M	6.94M	11.45M	33.76M	30.01M	11.67M	22.38M	8.23M	6M	38.57M	29.66M	25.96M
Other Current Liabilities	n/a	29.41M	45.36M	22.11M	24.35M	22.24M	27.35M	28.34M	22.61M	29.48M	16.57M	23.38M	72.62M	39.55M
Total Current Liabilities	n/a	42.28M	56.15M	36.92M	43.69M	62.91M	63.84M	46.31M	49.72M	43.52M	26.44M	66.2M	108.93M	71.44M
Long-Term Debt	n/a	6.51M	7.75M	7.53M	7.38M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	n/a	1.08M	1.09M	1.09M	1.1M	1.11M	1.11M	1.12M	2.04M	2.04M	2.39M	1.57M	1.89M	2.5M
Total Long-Term Liabilities	n/a	7.59M	8.84M	8.62M	10.55M	3.27M	4.34M	2.12M	3.06M	3.09M	3.48M	2.71M	3.05M	3.72M
Total Liabilities	n/a	49.87M	64.99M	45.55M	54.23M	66.17M	68.19M	48.44M	52.78M	46.61M	29.92M	68.91M	111.97M	75.16M
Total Debt	n/a	12.31M	8.82M	14.47M	18.83M	33.76M	30.01M	11.67M	22.38M	8.23M	6M	38.57M	29.66M	25.96M
Common Stock	n/a	5.73M	2.73M	2.66M	1.74M	1.28M	1.18M	1.06M	1M	809K	749K	657K	495K	569K
Retained Earnings	n/a	-577.54M	-545.63M	-523.72M	-490.29M	-475.65M	-444.54M	-413.99M	-385.98M	-356.95M	-332.54M	-276.48M	-242.86M	-174.35M
Comprehensive Income	n/a	4.26M	3.05M	4.37M	4.91M	4.53M	4.63M	4.26M	3.19M	4.79M	5.57M	2.11M	767K	-976K
Shareholders Equity	n/a	-13.68M	-3.34M	10.52M	8.18M	-4.5M	-322K	20.86M	8.74M	2.95M	24.17M	-15.97M	-40.07M	-22.39M
Total Investments	n/a	1.08M	855K	836K	742K	923K	803K	670K	805K	883K	1.61M	2.33M	3.9M	3.46M